Can We Cure Atherosclerosis?

被引：19

作者：

Robinson, Jennifer G. ^{[1
,2
,3
]}

Davidson, Michael H. ^{[4
]}

机构：

[1] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA

[2] Univ Iowa, Dept Med, Coll Publ Hlth, Iowa City, IA 52242 USA

[3] Carver Coll Med, Iowa City, IA 52242 USA

[4] Univ Chicago Med, Dept Cardiol, Chicago, IL USA

来源：

REVIEWS IN CARDIOVASCULAR MEDICINE | 2018年 / 19卷

关键词：

Atherosclerosis; Regression; Primary prevention; Familial hypercholesterolemia; Apolipoprotein B lipoproteins; PCSK9 monoclonal antibodies; Statins; LONG-TERM RISK; FAMILIAL HYPERCHOLESTEROLEMIA; LDL CHOLESTEROL; STATIN THERAPY; EFFICACY; SAFETY; DISEASE; METAANALYSIS; PROGRESSION; EVOLOCUMAB;

D O I：

10.3909/ricm19S1S0003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease mortality rates have begun to rise in the United States. Based on the large body of supportive evidence, we propose a proof-of-concept, first-in-human trial to cure atherosclerosis: CURing Early ATHEROsclerosis (CURE ATHERO). This trial is based on a model of intensive induction therapy for extensive, if not complete, plaque regression, followed by intermittent maintenance therapy. An extensive body of evidence has demonstrated the causal role of apolipoprotein B lipoproteins in atherosclerosis progression and data suggest intensive low-density lipoprotein cholesterol (LDL-C) lowering may have a substantial impact on earlier stages of atherosclerosis. Compared with lifetime treatment to prevent atherosclerosis progression, this induction-intermittent treatment model will minimize costs and maximize adherence and safety. (C) 2018 MedReviews (R), LLC

引用

页码：S20 / S24

页数：5

共 30 条

[1] Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome
Amor-Salamanca, Almudena
Castillo, Sergio
Gonzalez-Vioque, Emiliano
Dominguez, Fernando
Quintana, Lucia
Lluis-Ganella, Carla
Manuel Escudier, Juan
Ortega, Javier
Lara-Pezzi, Enrique
Alonso-Pulpon, Luis
Garcia-Pavia, Pablo
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (14) : 1732 - 1740
[2] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Baigent, C.
Blackwell, L.
Emberson, J.
Holland, L. E.
Reith, C.
Bhala, N.
Peto, R.
Barnes, E. H.
Keech, A.
Simes, J.
Collins, R.
[J]. LANCET, 2010, 376 (9753) : 1670 - 1681
[3] Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530]
[4] Plasma Cholesterol-Induced Lesion Networks Activated before Regression of Early, Mature, and Advanced Atherosclerosis
Bjorkegren, Johan L. M.
Hagg, Sara
Talukdar, Husain A.
Asl, Hassan Foroughi
Jain, Rajeev K.
Cedergren, Cecilia
Shang, Ming-Mei
Rossignoli, Aranzazu
Takolander, Rabbe
Melander, Olle
Hamsten, Anders
Michoel, Tom
Skogsberg, Josefin
[J]. PLOS GENETICS, 2014, 10 (02):
[5] The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
Boren, Jan
Williams, Kevin Jon
[J]. CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (05) : 473 - 483
[6] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, Christopher P.
Blazing, Michael A.
Giugliano, Robert P.
McCagg, Amy
White, Jennifer A.
Theroux, Pierre
Darius, Harald
Lewis, Basil S.
Ophuis, Ton Oude
Jukema, J. Wouter
De Ferrari, Gaetano M.
Ruzyllo, Witold
De Lucca, Paul
Im, KyungAh
Bohula, Erin A.
Reist, Craig
Wiviott, Stephen D.
Tershakovec, Andrew M.
Musliner, Thomas A.
Braunwald, Eugene
Califf, Robert M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) : 2387 - 2397
[7] Low LDL cholesterol in African Americans resulting from frequent nonsense mutations in PCSK9
Cohen, J
Pertsemlidis, A
Kotowski, IK
Graham, R
Garcia, CK
Hobbs, HH
[J]. NATURE GENETICS, 2005, 37 (03) : 328 - 328
[8] Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, Rory
Reith, Christina
Emberson, Jonathan
Armitage, Jane
Baigent, Colin
Blackwell, Lisa
Blumenthal, Roger
Danesh, John
Smith, George Davey
DeMets, David
Evans, Stephen
Law, Malcolm
MacMahon, Stephen
Martin, Seth
Neal, Bruce
Poulter, Neil
Preiss, David
Ridker, Paul
Roberts, Ian
Rodgers, Anthony
Sandercock, Peter
Schulz, Kenneth
Sever, Peter
Simes, John
Smeeth, Liam
Wald, Nicholas
Yusuf, Salim
Peto, Richard
[J]. LANCET, 2016, 388 (10059) : 2532 - 2561
[9] Emberson JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029849, 10.1016/S0140-6736(12)60367-5]
[10] Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Ference, Brian A.
Ginsberg, Henry N.
Graham, Ian
Ray, Kausik K.
Packard, Chris J.
Bruckert, Eric
Hegele, Robert A.
Krauss, Ronald M.
Raal, Frederick J.
Schunkert, Heribert
Watts, Gerald F.
Boren, Jan
Fazio, Sergio
Horton, Jay D.
Masana, Luis
Nicholls, Stephen J.
Nordestgaard, Borge G.
van de Sluis, Bart
Taskinen, Marja-Riitta
Tokgozoglu, Lale
Landmesser, Ulf
Laufs, Ulrich
Wiklund, Olov
Stock, Jane K.
Chapman, M. John
Catapano, Alberico L.
[J]. EUROPEAN HEART JOURNAL, 2017, 38 (32) : 2459 - 2472

← 1 2 3 →